Robert Cox

Robert Cox serves as an Assistant Professor at the Institute for Biomedical Sciences, Georgia State University, specializing in antiviral development against RNA viruses with pandemic potential.

Education:

• Ph.D. in Microbiology, University of Alabama at Birmingham (2013)

His research employs high-throughput screening in BSL2/BSL3 laboratories to identify small molecule inhibitors targeting viral polymerases of pathogens including SARS-CoV-2, measles, RSV, influenza, and parainfluenza viruses. Dr. Cox integrates cheminformatics with in vitro and in silico methods for rapid antiviral discovery as part of a national Antiviral Drug Development (AViDD) center, facilitating global collaborations for pandemic preparedness.

Dr. Cox directs a research laboratory equipped with automated high-throughput systems within the Institute for Biomedical Sciences. His work is conducted through the AViDD center collaboration, though specific grant mechanisms are not detailed in the source material.